NDC 72205-200
Roflumilast
Roflumilast
Roflumilast is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Novadoz Pharmaceuticals Llc. The primary component is Roflumilast.
| Product ID | 72205-200_4d25f69c-58b7-4e2a-b835-4d0c76a83c7c |
| NDC | 72205-200 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Roflumilast |
| Generic Name | Roflumilast |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-09-07 |
| Marketing Category | ANDA / |
| Application Number | ANDA208256 |
| Labeler Name | Novadoz Pharmaceuticals LLC |
| Substance Name | ROFLUMILAST |
| Active Ingredient Strength | 500 ug/1 |
| Pharm Classes | Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |